BISCEGLIA, DAVIDE ELIA
BISCEGLIA, DAVIDE ELIA
Dipartimento di Scienze Giuridiche Cesare Beccaria
Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study
2024 S. Harari, D. Elia, A. Caminati, J. Geginat, F. Luisi, G. Pelosi, C. Specchia, O. Torre, R. Trevisan, C. Vasco, M. Zompatori, R. Cassandro
Significant functional improvement in IPF patient treated with antifibrotic drugs: preliminary results and clinical outcome
2023 A. Caminati, I. Awad, D. Elia, R. Cassandro, F. Mozzanica, G. Pelosi, M. Zompatori, S. Harari
Coronary artery calcium score is a prognostic factor for mortality in idiopathic pulmonary fibrosis
2023 A. Caminati, M. Zompatori, N. Fuccillo, A. Sonaglioni, D. Elia, R. Cassandro, R. Trevisan, A. Rispoli, G. Pelosi, S. Harari
Lymphangioleiomyomatosis
2023 D. Elia, R. Cassandro, A. Caminati, F. Luisi, S. Harari
Pulmonary Langerhans Cell Histiocytosis
2023 S. Harari, D. Elia, J. Moss, A. Tazi
Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period
2022 A. Sonaglioni, M. Lombardo, A. Albini, D.M. Noonan, M. Re, R. Cassandro, D. Elia, A. Caminati, G.L. Nicolosi, S. Harari
Prognostic value of radiological index and clinical data in patients with COVID-19 infection
2022 D. Elia, F. Mozzanica, A. Caminati, I. Giana, L. Carli, F. Ambrogi, M. Zompatori, S. Harari